Daniela Furrer

MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation

Einas Yousef, Daniela Furrer, David Laperrière et al. · Modern Pathology · 2017 · 84 citations · Full text

Tumor Biology, Breast Oncology, Medicine +8

Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens

Daniela Furrer, Simon Jacob, Chantal Caron et al. · Diagnostic Pathology · 2013 · 44 citations · Full text

Gene Amplification, Breast Oncology, Engineering +22

Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines

Anna Burguin, Daniela Furrer, Geneviève Ouellette et al. · PLoS ONE · 2020 · 26 citations · Full text

Breast Oncology, Immunology, Immunotherapeutics +17

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer

Daniela Furrer, Jean‐Pierre Grégoire, Stéphane Turcotte et al. · PLoS ONE · 2019 · 25 citations · Full text

Remission of Diabetes Mellitus in Cats Cannot be Predicted by the Arginine Stimulation Test

F. Tschuor, Eric Zini, Stefan Schellenberg et al. · Journal of Veterinary Internal Medicine · 2010 · 23 citations · Full text